Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2010
07/28/2010EP2209480A1 Combination therapy with organic arsenicals
07/28/2010EP2209470A1 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field
07/28/2010EP2209375A1 Parp inhibitor compounds, compositions and methods of use
07/28/2010EP2016080B1 Dihydropyrazolopyrimidinone derivatives
07/28/2010EP1776387B1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2
07/28/2010EP1667711B1 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris)
07/28/2010EP1551844B1 Antitumoral analogs of lamellarins
07/28/2010EP1487856B1 Human antibodies specific to kdr and uses thereof
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010EP1432403B1 Liposome loading with metal ions
07/28/2010EP1369418B1 Quinazoline derivatives
07/28/2010EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
07/28/2010CN1927404B Application of siRNA inhibiting human Ezrin gene expression in esophagus cancer cell traveling invasion research
07/28/2010CN1883492B Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and preparation method thereof
07/28/2010CN1548434B Benzothiophene compounds and their preparation and medicine use
07/28/2010CN101790525A pharmaceutical compounds
07/28/2010CN101790513A 1,3-dihydroisoindole derivatives
07/28/2010CN101787374A Recombinant adenovirus vector capable of specifically proliferating in tumor cells based on micro RNA regulation and control, and construction method and application thereof
07/28/2010CN101787368A siRNA for restraining Z38 gene expression of human being and application thereof in preparing breast-tumor resisting medicine
07/28/2010CN101787367A siRNA for restraining MAEL gene expression of human being and application thereof in preparing anti-tumor medicine
07/28/2010CN101787366A DNA fragment for peculiarly inhibiting Rab27B gene expression and application thereof
07/28/2010CN101787358A Tet-Off Advanced human stably expressing high-transition nasopharyngeal carcinoma cell line S18, construction method thereof and application thereof
07/28/2010CN101787078A Collagen polypeptide, preparation method and application thereof
07/28/2010CN101787077A Preparation of 131I-thyroid stimulating hormone (TSH) and application thereof
07/28/2010CN101787075A Amino acid sequence with characteristic of bonding histone deacetylase 1 and expression vector thereof
07/28/2010CN101787072A Specific binding agents of human angiopoietin-2
07/28/2010CN101787070A Diosgenin deletion F-loop amino-acid ester derivatives and preparation method thereof
07/28/2010CN101787069A Diosgenin piperazine derivatives and preparation method thereof
07/28/2010CN101787066A Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors
07/28/2010CN101787065A Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors
07/28/2010CN101787064A Cytarabine prodrug derivatives and purposes thereof in resisting cancers and tumors
07/28/2010CN101787053A Platinum coordination compound as well as preparation method and medicinal application thereof
07/28/2010CN101787051A Water-soluble carboxyl-bridge dicaryon Pt (II) anti-tumor complex
07/28/2010CN101787025A Substituted-evodiamine anti-tumor and antifungal compounds and preparation method thereof
07/28/2010CN101787023A Dimer salt of quinoline alkaloid, preparation method and application thereof
07/28/2010CN101787019A Quinazoline derivatives
07/28/2010CN101787017A Optical pure quinazoline compound
07/28/2010CN101787013A Novel lipoamide derivatives and preparation method and pharmaceutical application thereof
07/28/2010CN101787007A Dimeric sesquiterpene compound and applications thereof
07/28/2010CN101786993A 1, 2, 3-triazole compound and application thereof in preparing indoleamine 2, 3-dioxygenase inhibitor
07/28/2010CN101786976A Selenium thioxo cysteine benzamide compound and preparation method and application thereof
07/28/2010CN101786975A Lipoamide series derivates, preparation method and pharmaceutical application thereof
07/28/2010CN101786974A Synthesis and production process of anti-cancer medicament bis(4-fluorobenzyl) trithioether and organic trithioether derivative
07/28/2010CN101786952A Anthraquinone compound and preparation method and medical application of lysine salt thereof
07/28/2010CN101785866A Preparation method of d-alpha-tocopheryl succinate monoester biomembrane covering
07/28/2010CN101785865A pH response type amphipathic stem-grafting polyphosphazenes feeding micelle and preparation method thereof
07/28/2010CN101785862A Infrared light triggering controllable drug carrier and preparation method thereof based on up-conversion material
07/28/2010CN101785860A Tegafur/layered duplex metal hydroxide nanometer hybrid and preparation method thereof
07/28/2010CN101785847A Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof
07/28/2010CN101785842A Pharmaceutical composition for leukemia treatment and preparation method thereof
07/28/2010CN101785838A Lung cancer treatment medicine
07/28/2010CN101785824A Chinese mediated liquor for tumor treatment
07/28/2010CN101785807A Application of traditional Chinese medicine compound Zuojin prescription in preparing medicine for treating gastric cancer
07/28/2010CN101785784A Compound of gold nanorods and zwitter ion molecules for photo-thermal therapy of cancer and preparation method thereof
07/28/2010CN101785777A Application of bufotalin std. in preparing medicament for treating lung tumors
07/28/2010CN101785767A Application of dehydrogenated silibinin diether in preparation of medicaments for preventing and treating leukemia
07/28/2010CN101785759A Nanoparticle for embedding medicinal Adriamycin as well as preparation method and application thereof
07/28/2010CN101785757A Taxol self-emulsifying preparation, preparation method and purpose thereof
07/28/2010CN101311173B Herpe-lactone, preparation method and use thereof
07/28/2010CN101279071B Chinese medicinal composition for curing esophagus cancer or cardiac cancer
07/28/2010CN101265302B Panax japonicus polysaccharides, preparation method and use thereof
07/28/2010CN101265212B Antineoplastic alkanna tinctoria ketoximes derivatives
07/28/2010CN101249069B Tilmicosin long-acting injection and method of preparing the same
07/28/2010CN101245112B Polyoses extracted from pistacia chinensis meal and extracting method thereof
07/28/2010CN101209334B Lung cancer-treating medicament and preparation thereof
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids
07/27/2010US7763729 Bicyclic heteroaromatic derivatives
07/27/2010US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases
07/27/2010US7763658 administering bis[thio-hydrazide amide] Compounds for treating multi-drug resistant cancer
07/27/2010US7763624 protein tyrosine kinase inhibitorssuch as 1-(but-3-enyl)-N3-(2,6-dimethylphenyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine, used for the treatment of autoimmune diseases and as antiproliferative or anticarcinogenic agents
07/27/2010US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
07/27/2010US7763621 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy
07/27/2010US7763620 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
07/27/2010US7763615 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics
07/27/2010US7763604 10-farnesyl-4,6,8-trihydroxy-dibenzodiazepin-11-one; ECO-4601; anticarcinogenic, antitumor agent; early stage of cancer; reducing side-effects on normal cells
07/27/2010US7763599 Retinoic esters with cholesterol; antiproliferative agents; disorders caused by abnormal cellular differentiation; psoriasis, cancers of skin, colon, lungs, breasts, prostate, or ovaries, leukemia, neuroblastomas, eczema, acne; improved wrinkle resistance, skin hydration, sebum secretions
07/27/2010US7763590 Nucleotide sequence complementary to wild-type gene; Rna strand which prevents gene expression
07/27/2010US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods
07/27/2010US7763422 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis
07/27/2010US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents
07/27/2010US7763248 Humanized collagen antibodies and related methods
07/27/2010US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
07/27/2010CA2481241C Fused quinoxaline derivatives as inhibitors of akt activity
07/27/2010CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
07/27/2010CA2463084C Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
07/27/2010CA2449031C Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
07/27/2010CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor
07/27/2010CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
07/27/2010CA2437587C Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotic agents
07/27/2010CA2436659C Cannabinoid receptor ligands
07/27/2010CA2427569C Selective glucocorticoid receptor agonists
07/27/2010CA2375820C The myostatin gene promoter and inhibition of activation thereof
07/27/2010CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
07/22/2010WO2010083501A2 Alpha-helix mimetic using a 2,5-oligopyrimidine scaffold
07/22/2010WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010083414A1 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer
07/22/2010WO2010083404A2 Linked myc-max small molecule inhibitors
07/22/2010WO2010083385A2 Compounds for reducing drug resistance and uses thereof
07/22/2010WO2010083311A2 Compositions and methods of use
1 ... 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 ... 2211